AU Patent

AU2010259588B2 — Tetracyclic compound

Assigned to Chugai Pharmaceutical Co Ltd · Expires 2015-05-28 · 11y expired

What this patent protects

Provided is a therapeutic and preventive agent effective against diseases accompanied by an abnormality of ALK, such as cancers, cancerous metastases, depression, or cognitive dysfunction, the agent containing an ALK-inhibitory compound. The agent comprises a medicinal compositio…

USPTO Abstract

Provided is a therapeutic and preventive agent effective against diseases accompanied by an abnormality of ALK, such as cancers, cancerous metastases, depression, or cognitive dysfunction, the agent containing an ALK-inhibitory compound. The agent comprises a medicinal composition containing a compound represented by general formula (I) [with respect to the symbols in the formula, see the definitions given in the description], a salt of the compound, or a solvate of either.

Drugs covered by this patent

Patent Metadata

Patent number
AU2010259588B2
Jurisdiction
AU
Classification
—
Expires
2015-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Chugai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.